1. Home
  2. TISI vs XBIT Comparison

TISI vs XBIT Comparison

Compare TISI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

HOLD

Current Price

$14.40

Market Cap

66.9M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.34

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
XBIT
Founded
1973
2005
Country
United States
United States
Employees
6800
N/A
Industry
Other Consumer Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
71.6M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
TISI
XBIT
Price
$14.40
$2.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
34.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
50.12
N/A
EPS
N/A
N/A
Revenue
$852,272,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.34
$2.09
52 Week High
$24.20
$3.62

Technical Indicators

Market Signals
Indicator
TISI
XBIT
Relative Strength Index (RSI) 51.37 46.53
Support Level $13.48 $2.32
Resistance Level $15.00 $2.69
Average True Range (ATR) 0.48 0.09
MACD 0.02 0.00
Stochastic Oscillator 42.42 51.85

Price Performance

Historical Comparison
TISI
XBIT

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: